Education
About Us
Working with TipRanks
Follow Us
Shanghai Fosun Pharmaceutical (Group) Co Ltd Class H (HK:2196)
:2196
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | ¥ 41.07B | ¥ 41.40B | ¥ 43.95B | ¥ 39.01B | ¥ 30.31B |
| Gross Profit | ¥ 19.70B | ¥ 19.68B | ¥ 20.78B | ¥ 18.78B | ¥ 16.88B |
| Operating Income | ¥ 4.25B | ¥ 3.31B | ¥ 8.30B | ¥ 6.31B | ¥ 4.72B |
| EBITDA | ¥ 8.60B | ¥ 7.55B | ¥ 7.87B | ¥ 8.70B | ¥ 7.23B |
| Net Income | ¥ 2.77B | ¥ 2.39B | ¥ 3.73B | ¥ 4.73B | ¥ 3.66B |
| Balance Sheet | |||||
| Cash & Short-Term Investments | ¥ 16.12B | ¥ 15.58B | ¥ 17.17B | ¥ 14.55B | ¥ 11.93B |
| Total Assets | ¥ 117.46B | ¥ 113.47B | ¥ 107.16B | ¥ 93.29B | ¥ 83.69B |
| Total Debt | ¥ 31.70B | ¥ 30.28B | ¥ 30.25B | ¥ 24.25B | ¥ 24.01B |
| Net Debt | ¥ 18.17B | ¥ 16.59B | ¥ 14.01B | ¥ 13.94B | ¥ 14.05B |
| Total Liabilities | ¥ 57.53B | ¥ 56.85B | ¥ 53.05B | ¥ 44.92B | ¥ 37.70B |
| Stockholders' Equity | ¥ 47.26B | ¥ 45.68B | ¥ 44.58B | ¥ 39.19B | ¥ 37.00B |
| Cash Flow | |||||
| Free Cash Flow | ¥ 66.79M | - | - | - | - |
| Operating Cash Flow | ¥ 4.48B | ¥ 3.41B | ¥ 4.22B | ¥ 3.95B | ¥ 2.58B |
| Investing Cash Flow | ¥ -3.61B | ¥ -3.82B | - | - | - |
| Financing Cash Flow | ¥ -1.00B | - | ¥ 4.43B | - | ¥ 1.47B |